Erbe Vio3
Payments companies reported to CMS as associated with Erbe Vio3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbe Vio3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbe Vio3
These are the largest totals companies reported as associated with Erbe Vio3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Madhusudhan Sunkavalli | Greenville, SC | Gastroenterology (Internal Medicine) | $357.20 |
| Arvind Trindade | New Brunswick, NJ | Gastroenterology (Internal Medicine) | $325.00 |
| Janak Shah | New Orleans, LA | Gastroenterology (Internal Medicine) | $290.17 |
| Matthew Rice | New Orleans, LA | Gastroenterology (Internal Medicine) | $270.00 |
| Neej Patel | New Orleans, LA | Gastroenterology (Internal Medicine) | $270.00 |
| Mohammad Abdallah | La Plata, MD | Gastroenterology (Internal Medicine) | $202.70 |
| Venkata Muddana | Cincinnati, OH | Gastroenterology (Internal Medicine) | $200.00 |
| Thomas Schussler | Montgomery, OH | Gastroenterology (Internal Medicine) | $200.00 |
| Galen Leung | Philadelphia, PA | Gastroenterology (Internal Medicine) | $200.00 |
| Nadav Sahar | Cincinnati, OH | Gastroenterology (Internal Medicine) | $200.00 |
Prescribed Erbe Vio3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.